These results implied that blocking the IL-6 signal or inhibiting the activation of the JAK/STAT signaling pathway could dramatically reduce tumor growth and metastasis by attenuating the accumulation and immunosuppressive capacity of e-MDSCs in vivo. This evidence concerns the gene IL6 and neoplasm.